Equities Analysts Issue Forecasts for BioLineRx Q2 Earnings
BioLineRx Ltd. (NASDAQ:BLRX – Free Report) – Stock analysts at HC Wainwright upped their Q2 2025 EPS estimates for BioLineRx in a research note issued on Wednesday, May 28th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($0.35) per share for the quarter, up from their prior estimate […]
